Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Makena: Formal Withdrawal Order Would Provide ‘Greater Certainty,’ Transparency – CDER
Mar 09 2023
•
By
Sue Sutter
CDER is seeking rock-solid assurance that Makena and its generics actually come off the market. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Review Pathways
More from Pathways & Standards